| Human anti-semaphorin 4D antibody |
2023-3-14 |
2023-5-30 |
|
| Combination therapy with semaphorin-4d blockade and htt-lowering agent for … |
2023-2-13 |
2023-8-17 |
|
| Predictive outcome profiling for use of an anti-semaphorin-4d binding molecule … |
2022-9-23 |
2023-3-30 |
|
| Use of semaphorin-4d binding molecules for treating neurodegenerative disorders |
2022-7-25 |
2022-9-01 |
|
| Anti-ccr8 antibodies and uses thereof |
2022-6-27 |
2022-8-01 |
|
| Integral membrane protein display on poxvirus extracellular enveloped virions |
2022-5-10 |
2022-8-09 |
|
| Improved methods for producing polynucleotide libraries in vaccinia virus/ … |
2022-4-19 |
2022-7-28 |
|
| Use of semaphorin-4d inhibitory molecules in combination with immune modulating … |
2022-2-03 |
2022-4-12 |
|
| Anti-cd100 antibodies and methods for using the same |
2022-1-31 |
2022-6-16 |
|
| Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy |
2021-12-08 |
2022-2-01 |
|
| Predictive outcome profiling for use of an anti-semaphorin-4d binding molecule … |
2021-9-27 |
2023-3-30 |
|
| Semaphorin-4d antagonists for use in cancer therapy |
2021-7-20 |
2021-9-30 |
|
| Use of semaphorin-4d binding molecules for the treatment of rett syndrome |
2021-6-21 |
2021-12-30 |
|
| Use of CXCL13 Binding Molecules to Promote Peripheral Nerve Regeneration |
2021-6-08 |
2023-2-14 |
|
| Integral membrane protein display on poxvirus extracellular enveloped virions |
2021-5-05 |
2021-11-11 |
|
| ANTI-CCR8 ANTIBODIES AND THEIR USES |
2021-1-06 |
2022-4-06 |
|
| Anti-cxcl13 antibodies and methods of using the same |
2020-9-24 |
2021-3-25 |
|
| Combined inhibition of semaphorin-4d and tgfb and compositions therefor |
2020-7-30 |
2022-6-08 |
|
| Treatment of cancer with a semaphorin-4d antibody in combination with an … |
2019-7-11 |
2023-6-01 |
|
| Early detection of glial cell activation in neurodegenerative or … |
2019-7-09 |
2019-9-26 |
|
| Use of semaphorin-4d binding molecules for modulation of blood brain barrier … |
2019-6-06 |
2019-11-28 |
|
| Use of semaphorin-4d binding molecules for treatment of atherosclerosis |
2019-2-28 |
2019-7-04 |
|
| Fusion proteins to facilitate selection of cells infected with specific … |
2018-11-01 |
2019-4-11 |
|
| Improved methods for producing polynucleotide libraries in vaccinia virus/ … |
2017-7-31 |
2022-5-27 |
|
| Integral membrane protein display on poxvirus extracellular enveloped virions |
2017-4-21 |
2022-3-25 |
|
| MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES |
2017-2-08 |
2017-11-02 |
|
| Anti-cd20 antibodies and methods of use |
2016-6-03 |
2016-12-29 |
|
| Modified glycolipids and methods of making and using the same |
2016-6-03 |
2018-10-30 |
2018-10-30 |
| Use of semaphorin-4d binding molecules to promote neurogenesis following stroke |
2015-3-11 |
2021-6-30 |
|
| Use of semaphorin-4d binding molecules for treating neurodegenerative disorders |
2014-9-11 |
2022-12-23 |
|
| Use of semaphorin-4d inhibitory molecules in combination with an immune … |
2014-6-20 |
2021-3-19 |
|
| Modified glycolipids and methods of making and using the same |
2014-2-07 |
2020-2-28 |
|
| Methods for increasing immunoglobulin A levels |
2014-1-31 |
2016-3-16 |
|
| Anti-sema4d antibodies and epitopes |
2013-3-27 |
2015-11-18 |
|
| ISOLATED ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF WHICH SPECIFICALLY … |
2013-3-08 |
2017-8-29 |
|
| Cxcl13 antagonist for the treatment of sjogren's syndrome |
2013-3-01 |
2021-2-16 |
2021-2-16 |
| Use of the combination of semaphorin-4d inhibitory molecules and vegf … |
2012-12-06 |
2013-6-06 |
|
| Use of semaphorin-4d binding molecules for modulation of blood brain barrier … |
2012-10-11 |
2016-8-02 |
|
| Use of the combination of semaphorin-4d inhibitory molecules and vegf … |
2011-12-15 |
2013-6-06 |
|
| Anti-vegf antibodies and uses thereof |
2011-6-14 |
2011-12-22 |
|
| anti-cd100 antibodies and methods for using them |
2010-5-07 |
2018-9-25 |
|
| Gene differentially expressed in breast and bladder cancer and encoded … |
2009-9-23 |
2009-10-15 |
|
| ANTI-IL-6 MONOCLONAL ANTIBODIES AND USES THEREOF |
2009-2-17 |
2009-8-03 |
|
| Anti-c35 antibody combination therapies and methods |
2008-12-23 |
2018-10-16 |
2018-10-16 |
| Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on … |
2008-5-22 |
2009-3-26 |
|
| SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES |
2008-4-10 |
2008-10-16 |
|
| Humanized anti-cd100 antibodies |
2008-2-13 |
2009-6-17 |
|
| In vitro methods of producing and identifying immunoglobulin molecules in … |
2007-8-17 |
2014-6-03 |
2014-6-03 |